Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Affymax, Inc. 

4001 Miranda Avenue

Palo Alto  California  94304  U.S.A.
Phone: 650-812-8700 Fax: 650-424-0832



Mosaic Technologies 

 Company News
Xstelos Announces Intention To Vote Against Affymax, Inc. (AFFY)'s Plan Of Liquidation At September 23, 2014 Special Meeting of Shareholders 9/22/2014 9:02:13 AM
Affymax, Inc. (AFFY) Reports Second Quarter 2014 Financial Results 8/1/2014 9:04:07 AM
Bay Area's Affymax, Inc. (AFFY) To Dissolve 6/24/2014 4:49:28 PM
Affymax, Inc. (AFFY) Drug Omontys® Terminal As Takeda Pharmaceutical Co. Ltd. (TKPYY) Switches Off Support 6/16/2014 10:49:39 AM
Affymax, Inc. (AFFY) Announces Update on Listing, Senior Leadership and Board Changes 6/7/2013 10:28:12 AM
Affymax, Inc. (AFFY) CEO Steps Down as Restructuring Firm Steps in 5/15/2013 8:57:51 AM
Affymax, Inc. (AFFY) Reports Fourth Quarter and Year-End 2012 Financial Results 4/2/2013 6:30:17 AM
Affymax, Inc. (AFFY) May File for Bankruptcy; Cuts 75 Pct of Workforce 3/19/2013 7:18:09 AM
Affymax, Inc. (AFFY) to Present at the Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/7/2013 6:17:14 AM
The New England Journal of Medicine Publishes Pivotal Trial Data for Affymax, Inc. (AFFY), and Takeda Pharmaceuticals's OMONTYS® (peginesatide) Injection for Treatment of Anemia in Adult Chronic Kidney Disease Patients on Hemodialysis 1/24/2013 9:01:03 AM